Jim Simons
APLS

Jim Simons’s Apellis Pharmaceuticals APLS Stock Holding History

Jim Simons’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$37.7M Buy
935,958
+302,900
+48% +$6.53M 0.06% 411
2025
Q4 		$15.9M Sell
633,058
-89,837
-12% -$2.11M 0.02% 714
2025
Q3 		$16.4M Buy
722,895
+711,907
+6,479% +$16.6M 0.02% 830
2025
Q2 		$190K Buy
+10,988
New +$203K ﹤0.01% 3183
2025
Q1 		– Sell
-271,913
Closed -$8.68M – 3440
2024
Q4 		$8.68M Sell
271,913
-100,418
-27% -$3.02M 0.01% 1108
2024
Q3 		$10.7M Buy
+372,331
New +$13.8M 0.02% 1009
2023
Q3 		– Sell
-138,513
Closed -$12.6M – 3632
2023
Q2 		$12.6M Buy
+138,513
New +$12M 0.02% 906
2023
Q1 		– Sell
-187,413
Closed -$9.69M – 3955
2022
Q4 		$9.69M Sell
187,413
-157,700
-46% -$8.36M 0.01% 1099
2022
Q3 		$23.6M Buy
+345,113
New +$20.4M 0.03% 596
2021
Q3 		– Sell
-20,211
Closed -$1.28M – 3448
2021
Q2 		$1.28M Sell
20,211
-353,302
-95% -$18.2M ﹤0.01% 2541
2021
Q1 		$16M Buy
373,513
+157,200
+73% +$7.44M 0.02% 909
2020
Q4 		$12.4M Buy
+216,313
New +$9.15M 0.01% 1023
2020
Q1 		– Sell
-19,513
Closed -$597K – 3425
2019
Q4 		$597K Buy
+19,513
New +$540K ﹤0.01% 2830
2019
Q2 		– Sell
-26,200
Closed -$511K – 3528
2019
Q1 		$511K Buy
+26,200
New +$412K ﹤0.01% 2917

Other funds holding APLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Jim Simons's APLS Position: Q1 2026 in Review

Jim Simons increased its Apellis Pharmaceuticals (APLS) stake by 48% in Q1 2026, buying an estimated $6.53M and bringing the position to 935,958 shares worth $37.7M. The position accounts for 0.06% of the portfolio, ranked #411.

Jim Simons first reported a position in APLS in Q1 2019 and has held it in 14 quarters since. 321 funds tracked by Wall St. Rank hold APLS as of Q1 2026.

  • Jim Simons held 935,958 shares of Apellis Pharmaceuticals worth $37.7M as of Q1 2026.
  • Jim Simons bought 302,900 Apellis Pharmaceuticals shares in Q1 2026, an estimated $6.53M.
  • Apellis Pharmaceuticals made up 0.06% of Jim Simons's portfolio in Q1 2026, its #411 holding.
  • Jim Simons first reported a position in Apellis Pharmaceuticals in Q1 2019 and has held it in 14 quarters since.
  • 321 funds tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.